Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma

References

• LeeYCSurgical resection of mesothelioma: an evidence-free practiceLancet201438499481080108124942632
   PubMedGoogle Scholar
• van ZandwijkNClarkeCHendersonDGuidelines for the diagnosis and treatment of malignant pleural mesotheliomaJ Thorac Dis201356E254E30724416529
   PubMed Web of Science ®Google Scholar
• HiddingaBIvan MeerbeeckJPSurgery in mesothelioma – where do we go after MARS?J Thorac Oncol20138552552923407570
   PubMed Web of Science ®Google Scholar
• RobinsonBWMuskAWLakeRAMalignant mesotheliomaLancet2005366948339740816054941
   PubMed Web of Science ®Google Scholar
• KamedaTTakahashiKKimRAsbestos: use, bans and disease burden in EuropeBull World Health Organ2014921179079725378740
   PubMedGoogle Scholar
• MineoTCAmbrogiVMalignant pleural mesothelioma: factors influencing the prognosisOncology (Williston Park)201226121164117523413596
   PubMedGoogle Scholar
• AignerKRKnappNToxicity profiles with systemic versus regional chemotherapyAignerKRStephensFOInduction Chemotherapy – Systemic and Locoregional2nd edBerlin, HeidelbergSpringer-Verlag2016497506
   Google Scholar
• AignerKRSelakEIsolated thoracic perfusion with chemofiltration (ITP-F) for advanced and pre-treated non-small-cell lung cancerAignerKRStephensFOInduction ChemotherapyBerlin, HeidelbergSpringer2011321330
   Google Scholar
• AignerKRGailhoferSSchwarzMHilgerNHypoxic abdominal perfusion for recurrent platin refractory ovarian cancerCancer Ther20086213220
   Google Scholar
• GuadagniSAignerKRPalumboGPharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancerJ Clin Pharmacol199838109369449807975
   PubMedGoogle Scholar
• GuadagniSRussoFAbateGStop-flow in mediastinum and thorax for resistant lymphomaHepatogastroenterology2000473237838210791194
   PubMedGoogle Scholar
• AignerKRMüllerHWaltherHLinkKHDrug filtration in high-dose regional chemotherapyAignerKRPattYZLinkKHKreidlerJRegional Cancer Treatment29BaselKarger1988261280
   Google Scholar
• RuschVBaldiniEHBuenoRThe role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11–14, 2012, Boston, MAJ Thorac Cardiovasc Surg2013145490991023415687
   PubMed Web of Science ®Google Scholar
• OpitzIManagement of malignant pleural mesothelioma – the European experienceJ Thorac Dis20146Suppl 2S238S25224868442
   PubMed Web of Science ®Google Scholar
• ShersherDDLiptayMJMultimodality treatment of pleural mesotheliomaSurg Oncol Clin N Am201322234535523453339
   PubMed Web of Science ®Google Scholar
• TreasureTLang-LazdunskiLWallerDExtra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyLancet Oncol201112876377221723781
   PubMed Web of Science ®Google Scholar
• RuschVWGirouxDKennedyCInitial analysis of the international association for the study of lung cancer mesothelioma databaseJ Thorac Oncol20127111631163923070243
   PubMed Web of Science ®Google Scholar
• BerghmansTPaesmansMLalamiYActivity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysisLung Cancer2002382111112112399121
   PubMed Web of Science ®Google Scholar
• VogelzangNJChemotherapy for malignant pleural mesotheliomaLancet200837196251640164218486725
   PubMed Web of Science ®Google Scholar
• van MeerbeeckJPGaafarRManegoldCRandomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of CanadaJ Clin Oncol200523286881688916192580
   PubMed Web of Science ®Google Scholar
• ZalcmanGMazieresJMargeryJBevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomized, controlled, open-label, phase 3 trialLancet2016387100261405141426719230
   PubMed Web of Science ®Google Scholar
• CeresoliGLGrossoFZucaliPAPrognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter surveyBr J Cancer2014111222022624918816
   PubMed Web of Science ®Google Scholar
• ChapmanAMulrennanSLaddBMuersMFPopulation based epidemiology and prognosis of mesothelioma in Leeds, UKThorax200863543543918202164
   PubMedGoogle Scholar
• GrossoFScagliottiGVSystemic treatment of malignant pleural mesotheliomaFuture Oncol20128329330522409465
   PubMedGoogle Scholar
• CeresoliGLZucaliPAGianoncelliLLorenziESantoroASecond-line treatment for malignant pleural mesotheliomaCancer Treat Rev2010361243219879055
   PubMed Web of Science ®Google Scholar
• MansfieldASSymanowskiJTPeikertTSystematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trialsLung Cancer201486213313625217189
   PubMed Web of Science ®Google Scholar
• BaasPBuikhuisenWDalesioOA multicenter, randomized phase III maintenance study of thalidomide (arm A) versus observation (arm B) in patients with malignant pleural mesothelioma (MPM) after induction chemotherapy. In: ASCO Annual MeetingJ Clin Oncol201129
   Google Scholar
• KrugLMKindlerHLCalvertHVorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trialLancet Oncol201516444745625800891
   PubMed Web of Science ®Google Scholar
• RemonJLianesPMartinezSVelascoMQuerolRZanuiMMalignant mesothelioma: new insights into a rare diseaseCancer Treat Rev201339658459123276688
   PubMed Web of Science ®Google Scholar
• RemonJRequartNCorralJLianesPMalignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategiesCancer Treat Rev2015411273425467107
   PubMed Web of Science ®Google Scholar
• SugarbakerDJGillRRYeapBYHyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resectionJ Thorac Cardiovasc Surg2013145495596323434448
   PubMed Web of Science ®Google Scholar
• BijelicLJonsonASugarbakerPHSystematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancerAnn Oncol200718121943195017496308
   PubMed Web of Science ®Google Scholar
• RiedMPotzgerTBrauneNCytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experienceEur J Cardiothorac Surg201343480180722885228
   PubMedGoogle Scholar
• VoglTJLindemayrSNaquibNNNonselective transarterial chemoperfusion: a palliative treatment for malignant pleural mesotheliomaRadiology2013266264965623151824
   PubMedGoogle Scholar